[go: up one dir, main page]

FI972669A - Peptidin p277 analogeja ja niitä sisältäviä farmaseuttisia koostumuksia diabeteksen hoitamiseksi ja diagnosoimiseksi - Google Patents

Peptidin p277 analogeja ja niitä sisältäviä farmaseuttisia koostumuksia diabeteksen hoitamiseksi ja diagnosoimiseksi Download PDF

Info

Publication number
FI972669A
FI972669A FI972669A FI972669A FI972669A FI 972669 A FI972669 A FI 972669A FI 972669 A FI972669 A FI 972669A FI 972669 A FI972669 A FI 972669A FI 972669 A FI972669 A FI 972669A
Authority
FI
Finland
Prior art keywords
analogues
diabetes
peptide
diagnosis
treatment
Prior art date
Application number
FI972669A
Other languages
English (en)
Swedish (sv)
Other versions
FI972669A0 (fi
FI118373B (fi
Inventor
Irun R Cohen
Dana Elias
Matiyahu Fridkin
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI972669(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of FI972669A0 publication Critical patent/FI972669A0/fi
Publication of FI972669A publication Critical patent/FI972669A/fi
Application granted granted Critical
Publication of FI118373B publication Critical patent/FI118373B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI972669A 1994-12-21 1997-06-19 Peptidin p277 analogeja ja niitä sisältäviä farmaseuttisia koostumuksia diabeteksen hoitamiseksi ja diagnosoimiseksi FI118373B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IL11209494 1994-12-21
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL11446095 1995-07-05
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
US9516596 1995-12-20
PCT/US1995/016596 WO1996019236A1 (en) 1994-12-21 1995-12-20 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES

Publications (3)

Publication Number Publication Date
FI972669A0 FI972669A0 (fi) 1997-06-19
FI972669A true FI972669A (fi) 1997-08-15
FI118373B FI118373B (fi) 2007-10-31

Family

ID=26322965

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972669A FI118373B (fi) 1994-12-21 1997-06-19 Peptidin p277 analogeja ja niitä sisältäviä farmaseuttisia koostumuksia diabeteksen hoitamiseksi ja diagnosoimiseksi

Country Status (31)

Country Link
EP (1) EP0820303B1 (fi)
JP (2) JP3420245B2 (fi)
KR (1) KR100400480B1 (fi)
CN (1) CN1233417C (fi)
AR (1) AR002949A1 (fi)
AT (1) ATE242005T1 (fi)
AU (1) AU707835B2 (fi)
BR (1) BR9510102A (fi)
CA (1) CA2208274C (fi)
CZ (1) CZ293784B6 (fi)
DE (2) DE820303T1 (fi)
DK (1) DK0820303T3 (fi)
ES (1) ES2201137T3 (fi)
FI (1) FI118373B (fi)
HR (1) HRP950612B1 (fi)
HU (1) HU224160B1 (fi)
IL (1) IL116499A0 (fi)
IS (1) IS1966B (fi)
MX (1) MX9704738A (fi)
NO (1) NO317350B1 (fi)
NZ (1) NZ301440A (fi)
PL (1) PL184145B1 (fi)
PT (1) PT820303E (fi)
RO (1) RO116777B1 (fi)
RS (1) RS49517B (fi)
SI (1) SI0820303T1 (fi)
TR (1) TR199501630A2 (fi)
TW (1) TW496872B (fi)
UA (1) UA42040C2 (fi)
UY (1) UY24130A1 (fi)
WO (1) WO1996019236A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
DE69724619T2 (de) * 1996-05-14 2004-07-01 Winnacker, Ernst-Ludwig, Prof. Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können
WO2002016549A2 (en) * 2000-08-25 2002-02-28 Yeda Research And Development Co. Ltd. METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
WO2003063759A2 (en) 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
AU2005207891B2 (en) 2004-01-28 2010-04-01 Andromeda Biotech Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
WO2006072946A2 (en) 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
US8211430B2 (en) 2005-03-04 2012-07-03 Curedm Group Holdings, Llc Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
CA2726759C (en) 2005-05-25 2016-02-16 Curedm Group Holdings, Llc Human proislet peptide, derivatives and analogs thereof, and methods of using same
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
US8785400B2 (en) 2006-11-22 2014-07-22 Curedm Group Holdings, Llc Methods and compositions relating to islet cell neogenesis
CA2698100C (en) 2007-08-30 2017-06-06 Curedm, Inc. Compositions and methods of using proislet peptides and analogs thereof
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
WO2013128450A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
NO317350B1 (no) 2004-10-18
DE69531004D1 (de) 2003-07-10
CA2208274C (en) 2005-12-06
WO1996019236A1 (en) 1996-06-27
EP0820303A4 (fi) 1998-03-11
AU707835B2 (en) 1999-07-22
SI0820303T1 (en) 2003-10-31
IS4510A (is) 1997-06-19
CN1175214A (zh) 1998-03-04
JP3554319B2 (ja) 2004-08-18
HU224160B1 (hu) 2005-06-28
EP0820303A1 (en) 1998-01-28
JPH10511649A (ja) 1998-11-10
HUT78092A (hu) 1999-09-28
DE820303T1 (de) 1999-05-20
RS49517B (sr) 2006-10-27
YU78795A (sh) 1998-05-15
TW496872B (en) 2002-08-01
HRP950612A2 (en) 1997-10-31
BR9510102A (pt) 1997-11-25
ES2201137T3 (es) 2004-03-16
FI972669A0 (fi) 1997-06-19
PL321091A1 (en) 1997-11-24
CZ190897A3 (en) 1997-11-12
NO972849L (no) 1997-08-13
KR100400480B1 (ko) 2003-12-31
JP2004026797A (ja) 2004-01-29
IS1966B (is) 2004-12-15
UA42040C2 (uk) 2001-10-15
RO116777B1 (ro) 2001-06-29
CN1233417C (zh) 2005-12-28
AR002949A1 (es) 1998-05-27
AU4686696A (en) 1996-07-10
ATE242005T1 (de) 2003-06-15
PT820303E (pt) 2003-10-31
PL184145B1 (pl) 2002-09-30
FI118373B (fi) 2007-10-31
CZ293784B6 (cs) 2004-07-14
DK0820303T3 (da) 2003-10-06
HRP950612B1 (en) 2003-12-31
IL116499A0 (en) 1996-03-31
JP3420245B2 (ja) 2003-06-23
CA2208274A1 (en) 1996-06-27
DE69531004T2 (de) 2004-02-05
MX9704738A (es) 1997-10-31
NZ301440A (en) 2000-01-28
UY24130A1 (es) 1996-06-11
TR199501630A2 (tr) 1996-07-21
EP0820303B1 (en) 2003-06-04
NO972849D0 (no) 1997-06-19

Similar Documents

Publication Publication Date Title
FI972669A0 (fi) Peptidin p277 analogeja ja niitä sisältäviä farmaseuttisia koostumuksia diabeteksen hoitamiseksi ja diagnosoimiseksi
IT1243541B (it) Dispositivo di somministrazione in particolare di sostanza farmaceutica
ATE220542T1 (de) Zweiteilige kapsel zur aufnahme von pharmazeutischen zubereitungen für pulverinhalatoren
IT9020025A0 (it) Dispositivo per la somministrazione di sostanze medicamentose in polvere
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
ATE203415T1 (de) Orales verabreichungssystem von chemischmodifizierten proteinen g-csf
FR2577557B1 (fr) Peptides et derives peptidiques, leur preparation, leur utilisation en therapeutique et compositions pharmaceutiques les contenant
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
DK385488A (da) Farmaceutisk praeparat indeholdende somatostatinanaloge
SE8602530D0 (sv) Nasal pharmaceutical compositions
IT8922164A0 (it) Composizione farmaceutica e procedimento per la sua preparazione
DE69512929D1 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
PT87111A (pt) Process for the preparation of cyclic peptides and of pharmaceutical compositions containing the same
IT1153182B (it) Formulazioni farmaceutiche comprendenti insulina umana e c-peptide umano
BE894188A (fr) Formulations pharmaceutiques comprenant de l'insuline et de la pro-insuline humaine
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
FI971427A (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
RU94002476A (ru) Лекарственное средство
DK590987A (da) Peptid og farmaceutisk praeparat indeholdende et saadant peptid
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
IL114460A0 (en) Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
ZA9510828B (en) Peptide p277 analogs and phamarceutical compositions comprising them for treatment or diagnosis of diabetes

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118373

Country of ref document: FI

MA Patent expired